Correlation Between Clearfield and Passage Bio
Can any of the company-specific risk be diversified away by investing in both Clearfield and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clearfield and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clearfield and Passage Bio, you can compare the effects of market volatilities on Clearfield and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clearfield with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clearfield and Passage Bio.
Diversification Opportunities for Clearfield and Passage Bio
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Clearfield and Passage is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Clearfield and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Clearfield is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clearfield are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Clearfield i.e., Clearfield and Passage Bio go up and down completely randomly.
Pair Corralation between Clearfield and Passage Bio
Given the investment horizon of 90 days Clearfield is expected to under-perform the Passage Bio. But the stock apears to be less risky and, when comparing its historical volatility, Clearfield is 4.07 times less risky than Passage Bio. The stock trades about -0.12 of its potential returns per unit of risk. The Passage Bio is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 65.00 in Passage Bio on September 21, 2024 and sell it today you would lose (4.00) from holding Passage Bio or give up 6.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Clearfield vs. Passage Bio
Performance |
Timeline |
Clearfield |
Passage Bio |
Clearfield and Passage Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Clearfield and Passage Bio
The main advantage of trading using opposite Clearfield and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clearfield position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.Clearfield vs. Passage Bio | Clearfield vs. Black Diamond Therapeutics | Clearfield vs. Alector | Clearfield vs. Century Therapeutics |
Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |